With medical letters and the general health of the U.S. Presidential candidates being the big topic of discussion last week, we were all treated to analyses of issues like blood clots and BMI and other topics.
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
